Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information


Roanoke, USA
5238 Valleypoint Parkway
Roanoke, VA, 24019


Chief Technical Officer


TOTAL $27.3M
Series B, 2/2011
Carlyle Group
Delphi Ventures
ITOCHU Corporation
Partial Close, 7/2013



ELENZA, Inc. is developing the world’s first electronic “AutoFocal” Intraocular Lens to compete in the multi-billion dollar IOL market. Elenza’s highly proprietary next generation Accommodating IOL is designed to give patients a complete visual range, providing effective near, intermediate and distance vision. These electro-active IOLs use a proprietary combination of liquid-crystal chemistry, electricity, and integrated-circuitry to create smart optics, which will provide patients with the ability to see more naturally and clearly over the full range of vision. The technology includes an electro-active switchable element that automatically adjusts focusing power electronically, in milliseconds, to maintain constant in-focus vision for various working needs and/or light environments. The lens is controlled by a micro-sized power-cell with an expected 50+ year rechargeable cycle life.

Recent Milestones

  • Dollar
    ELENZA received $3.33M in Partial Close funding. (7/8/13)
    Posted 7/10/13 at 1:43am via
  • Dollar
    ELENZA received $24M in Series B funding. (2/8/11)
    Posted 2/8/11 at 6:33pm via
  • Check
    ELENZA added Rudy Mazzocchi as CEO.
    Posted 2/8/11 at 6:33pm



ELENZA screenshot
Above: Homepage
Uploaded: 7/10/13


  1. ELENZA Closes $24 Million Series B Financing to Fund Development of New Electronic AutoFocal Intraocular Lens ( [edit]
  2. SEC ( [edit]
Edit This Page
Last Edited 2/27/14

Revision History RSS Picture


Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API


Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy